Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Enerdynamic Hybrid Technologies Corp. EDYYF

Enerdynamic Hybrid Technologies, is a Canadian-based company delivering leading-edge energy solutions. EHT’s clean and renewable energy solutions are easily deployed and customizable. The Company is able to combine and integrate solar, battery storage technology, and energy efficient structures that qualify for being “NET ZERO”.


GREY:EDYYF - Post by User

Comment by etceteraon Jan 26, 2021 4:00pm
196 Views
Post# 32390339

RE:Part of Dec 22 press release

RE:Part of Dec 22 press releaseSurely a good news

It's not about consolidation as they do not need to halt transaction to announce the date of the consolidation if decided to do it.

A good example of is HEMOSTENIX  ( HEM ).

They did a 20 :1 consolidation and transaction were never halt

Here a summary

On news dec  01, 2020

The shares are currently trading at $0.01. However, the company has obtained shareholder approval for a 20 for one share consolidation.

On Dec 18, 2020

Hemostemix Announces Closing of Existing Private Placement and Announces a New Private Placement

New Private Placement

The Company is pleased to announce that it will raise up to an additional $2,750,000 by way of a non-brokered private placement of units at $0.015 each (the "Units") (the "Offering"). Each Unit of the Offering is comprised of one common share (each a "Share") and one share purchase warrant (each a "Warrant"). Each Warrant will entitle the holder to acquire one additional Share in the capital of the Company at a price of $0.05 per Warrant for a period of one year from the date the Units are issued subject to the accelerated expiry provision described below.

On dec 23,2020

Hemostemix Announces Corporate Update

Calgary, Alberta--(Newsfile Corp. - December 23, 2020) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") The Company is pleased to announce that the previously disclosed proposed consolidation of the common shares of the Company on the basis of twenty pre-consolidation shares for one post-consolidation share (the "Consolidation") will take effect, subject to final acceptance by the TSX Venture Exchange, on or about December 30, 2020 under new CUSIP number 423694306.

There will be no name change or trading symbol change in conjunction with the Consolidation. The Consolidation was approved by the Company's shareholders at the Annual General Meeting held on May 6, 2020.

Following the Consolidation, the total issued and outstanding common shares of the Company will be approximately 46,368,985.




<< Previous
Bullboard Posts
Next >>